The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Thrombolysis for acute ischaemic stroke
Open accessAbstract
BACKGROUND: Most strokes are due to blockage of an artery in the brain by a blood clot. Prompt treatment with thrombolytic drugs can restore blood flow before major brain damage has occurred and improve recovery after stroke in some people. Thrombolytic drugs, however, can also cause serious bleeding in the brain, which can be fatal. One drug, recombinant tissue plasminogen activator (rt-PA), is licensed for use in selected patients within 4.5 hours of stroke in Europe and within three hours in the USA. There is an upper age limit of 80 years in some countries, and a limitation to mainly non-severe stroke in others. Forty per cent more data are available since this review was last updated in 2009. OBJECTIVES: To determine whether, and in what circumstances, thrombolytic therapy might be an effective and safe treatment for acute ischaemic stroke. SEARCH METHODS: We searched the Cochrane Stroke Group Trials Register (last searched November 2013), MEDLINE (1966 to November 2013) and EMBASE (1980 to November 2013). We also handsearched conference proceedings and journals, searched reference lists and contacted pharmaceutical companies and trialists. SELECTION CRITERIA: Randomised trials of any thrombolytic agent compared with control in people with definite ischaemic stroke. DATA COLLECTION AND ANALYSIS: Two review authors applied the inclusion criteria, extracted data and assessed trial quality. We verified the extracted data with investigators of all major trials, obtaining additional unpublished data if available. MAIN RESULTS: We included 27 trials, involving 10,187 participants, testing urokinase, streptokinase, rt-PA, recombinant pro-urokinase or desmoteplase. Four trials used intra-arterial administration, while the rest used the intravenous route. Most data come from trials that started treatment up to six hours after stroke. About 44% of the trials (about 70% of the participants) were testing intravenous rt-PA. In earlier studies very few of the participants (0.5%) were aged over 80 years; in this update, 16% of participants are over 80 years of age due to the inclusion of IST-3 (53% of participants in this trial were aged over 80 years). Trials published more recently utilised computerised randomisation, so there are less likely to be baseline imbalances than in previous versions of the review. More than 50% of trials fulfilled criteria for high-grade concealment; there were few losses to follow-up for the main outcomes.Thrombolytic therapy, mostly administered up to six hours after ischaemic stroke, significantly reduced the proportion of participants who were dead or dependent (modified Rankin 3 to 6) at three to six months after stroke (odds ratio (OR) 0.85, 95% confidence interval (CI) 0.78 to 0.93). Thrombolytic therapy increased the risk of symptomatic intracranial haemorrhage (OR 3.75, 95% CI 3.11 to 4.51), early death (OR 1.69, 95% CI 1.44 to 1.98; 13 trials, 7458 participants) and death by three to six months after stroke (OR 1.18, 95% CI 1.06 to 1.30). Early death after thrombolysis was mostly attributable to intracranial haemorrhage. Treatment within three hours of stroke was more effective in reducing death or dependency (OR 0.66, 95% CI 0.56 to 0.79) without any increase in death (OR 0.99, 95% CI 0.82 to 1.21; 11 trials, 2187 participants). There was heterogeneity between the trials. Contemporaneous antithrombotic drugs increased the risk of death. Trials testing rt-PA showed a significant reduction in death or dependency with treatment up to six hours (OR 0.84, 95% CI 0.77 to 0.93, P = 0.0006; 8 trials, 6729 participants) with significant heterogeneity; treatment within three hours was more beneficial (OR 0.65, 95% CI 0.54 to 0.80, P < 0.0001; 6 trials, 1779 participants) without heterogeneity. Participants aged over 80 years benefited equally to those aged under 80 years, particularly if treated within three hours of stroke. AUTHORS' CONCLUSIONS: Thrombolytic therapy given up to six hours after stroke reduces the proportion of dead or dependent people. Those treated within the first three hours derive substantially more benefit than with later treatment. This overall benefit was apparent despite an increase in symptomatic intracranial haemorrhage, deaths at seven to 10 days, and deaths at final follow-up (except for trials testing rt-PA, which had no effect on death at final follow-up). Further trials are needed to identify the latest time window, whether people with mild stroke benefit from thrombolysis, to find ways of reducing symptomatic intracranial haemorrhage and deaths, and to identify the environment in which thrombolysis may best be given in routine practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Furlan, A., Higashida, R., Wechsler, L., Gent, M., Rowley, H., Kase, C., Pessin, M., Ahuja, A., Callahan, F., Clark, W. M., et al. (1999) · JAMA · doi:10.1001/jama.282.21.2003 · Cited by 3,073
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15692-4 · Cited by 2,557
Benardete, E. A., & Nair, A. K. (2015) · Cerebrovascular Diseases Extra · doi:10.1159/000370060 · Cited by 2,546
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Lees, K. R., Bluhmki, E., von Kummer, R., Brott, T. G., Toni, D., Grotta, J. C., Albers, G. W., Kaste, M., Marler, J. R., Hamilton, S. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60491-6 · Cited by 2,184
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Aoki, J., Kimura, K., Shibazaki, K., & Sakamoto, Y. (2013) · Cerebrovascular Diseases Extra · doi:10.1159/000348552 · Cited by 1,929
del Zoppo, G. J., Higashida, R. T., Furlan, A. J., Pessin, M. S., Rowley, H. A., & Gent, M. (1998) · Stroke · doi:10.1161/01.str.29.1.4 · Cited by 1,239
Self-citationClark, W. M., Wissman, S., Albers, G. W., Jhamandas, J. H., Madden, K. P., Hamilton, S., & for the ATLANTIS Study Investigators (1999) · JAMA · doi:10.1001/jama.282.21.2019 · Cited by 1,186
Davis, S. M., Donnan, G. A., Parsons, M. W., Levi, C., Butcher, K. S., Peeters, A., Barber, P. A., Bladin, C., De Silva, D. A., Byrnes, G., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70044-9 · Cited by 1,052
Hacke, W., Albers, G., Al-Rawi, Y., Bogousslavsky, J., Davalos, A., Eliasziw, M., Fischer, M., Furlan, A., Kaste, M., Lees, K. R., et al. (2005) · Stroke · doi:10.1161/01.str.0000149938.08731.2c · Cited by 1,015
Wardlaw, J. M., Murray, V., Berge, E., del Zoppo, G., Sandercock, P., Lindley, R. L., & Cohen, G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60738-7 · Cited by 1,010
Self-citationLarrue, V., von Kummer, R., Müller, A., & Bluhmki, E. (2001) · Stroke · doi:10.1161/01.str.32.2.438 · Cited by 1,006
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2109 · Cited by 880
Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study
Marler, J. R., Tilley, B. C., Lu, M., Brott, T. G., Lyden, P. C., Grotta, J. C., Broderick, J. P., Levine, S. R., Frankel, M. P., Horowitz, S. H., et al. (2000) · Neurology · doi:10.1212/wnl.55.11.1649 · Cited by 862
Fiorelli, M., Bastianello, S., von Kummer, R., del Zoppo, G. J., Larrue, V., Lesaffre, E., Ringleb, A. P., Lorenzano, S., Manelfe, C., & Bozzao, L. (1999) · Stroke · doi:10.1161/01.str.30.11.2280 · Cited by 777
Self-citationEffects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Kwiatkowski, T. G., Libman, R. B., Frankel, M., Tilley, B. C., Morgenstern, L. B., Lu, M., Broderick, J. P., Lewandowski, C. A., Marler, J. R., Levine, S. R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402302 · Cited by 647
Multicentre Acute Stroke Trial—Italy (MAST-I) Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92049-8 · Cited by 633
Lewandowski, C. A., Frankel, M., Tomsick, T. A., Broderick, J., Frey, J., Clark, W., Starkman, S., Grotta, J., Spilker, J., Khoury, J., et al. (1999) · Stroke · doi:10.1161/01.str.30.12.2598 · Cited by 628
The Interventional Management of Stroke (IMS) II Study
The IMS II Trial Investigators (2007) · Stroke · doi:10.1161/strokeaha.107.483131 · Cited by 611
Acute stroke: usefulness of early CT findings before thrombolytic therapy.
von Kummer, R., Allen, K. L., Holle, R., Bozzao, L., Bastianello, S., Manelfe, C., Bluhmki, E., Ringleb, P., Meier, D. H., & Hacke, W. (1997) · Radiology · doi:10.1148/radiology.205.2.9356611 · Cited by 587
Hacke, W., Furlan, A. J., Al-Rawi, Y., Davalos, A., Fiebach, J. B., Gruber, F., Kaste, M., Lipka, L. J., Pedraza, S., Ringleb, P. A., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70267-9 · Cited by 574
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350301 · Cited by 570
Generalized Efficacy of t-PA for Acute Stroke: Subgroup Analysis of the NINDS t-PA Stroke Trial
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2119 · Cited by 559
Furlan, A. J., Eyding, D., Albers, G. W., Al-Rawi, Y., Lees, K. R., Rowley, H. A., Sachara, C., Soehngen, M., Warach, S., & Hacke, W. (2006) · Stroke · doi:10.1161/01.str.0000217403.66996.6d · Cited by 540
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial
Bruno, A., Levine, S. R., Frankel, M. R., Brott, T. G., Lin, Y., Tilley, B. C., Lyden, P. D., Broderick, J. P., Kwiatkowski, T. G., Fineberg, S. E., et al. (2002) · Neurology · doi:10.1212/wnl.59.5.669 · Cited by 516
Yamaguchi, T., Mori, E., Minematsu, K., Nakagawara, J., Hashi, K., Saito, I., & Shinohara, Y. (2006) · Stroke · doi:10.1161/01.str.0000227191.01792.e3 · Cited by 515
The European Cooperative Acute Stroke Study (ECASS)
Kaste, M., Fieschi, C., Hacke, W., Lesaffre, E., Verstraete, M., & Fröhlich, J. (1993) · Thrombolytic Therapy in Acute Ischemic Stroke II · doi:10.1007/978-3-642-78061-5_10 · Cited by 487
Ogawa, A., Mori, E., Minematsu, K., Taki, W., Takahashi, A., Nemoto, S., Miyamoto, S., Sasaki, M., & Inoue, T. (2007) · Stroke · doi:10.1161/strokeaha.107.488551 · Cited by 481
Larrue, V., von Kummer, R., del Zoppo, G., & Bluhmki, E. (1997) · Stroke · doi:10.1161/01.str.28.5.957 · Cited by 474
Self-citationIntravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke
Mori, E., Yoneda, Y., Tabuchi, M., Yoshida, T., Ohkawa, S., Ohsumi, Y., Kitano, K., Tsutsumi, A., & Yamadori, A. (1992) · Neurology · doi:10.1212/wnl.42.5.976 · Cited by 472
Lindsberg, P. J., & Mattle, H. P. (2006) · Stroke · doi:10.1161/01.str.0000202582.29510.6b · Cited by 462
Molina, C. A., Ribo, M., Rubiera, M., Montaner, J., Santamarina, E., Delgado-Mederos, R., Arenillas, J. F., Huertas, R., Purroy, F., Delgado, P., et al. (2006) · Stroke · doi:10.1161/01.str.0000199064.94588.39 · Cited by 452
Clark, W. M., Albers, G. W., Madden, K. P., & Hamilton, S. (2000) · Stroke · doi:10.1161/01.str.31.4.811 · Cited by 416
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
Fagan, S. C., Morgenstern, L. B., Petitta, A., Ward, R. E., Tilley, B. C., Marler, J. R., Levine, S. R., Broderick, J. P., Kwiatkowski, T. G., Frankel, M., et al. (1998) · Neurology · doi:10.1212/wnl.50.4.883 · Cited by 385
Lack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke
Patel, S. C. (2001) · JAMA · doi:10.1001/jama.286.22.2830 · Cited by 378
Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery.
Mori, E., Tabuchi, M., Yoshida, T., & Yamadori, A. (1988) · Stroke · doi:10.1161/01.str.19.7.802 · Cited by 362
Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration
Donnan, G. A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120039031 · Cited by 360
Underlying Structure of the National Institutes of Health Stroke Scale: Results of a Factor Analysis
Lyden, P., Lu, M., Jackson, C., Marler, J., Kothari, R., Brott, T., & Zivin, J. (1999) · Stroke · doi:10.1161/01.str.30.11.2347 · Cited by 354
Bluhmki, E., Chamorro, Á., Dávalos, A., Machnig, T., Sauce, C., Wahlgren, N., Wardlaw, J., & Hacke, W. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70264-9 · Cited by 346
Self-citationHemmen, T. M., Raman, R., Guluma, K. Z., Meyer, B. C., Gomes, J. A., Cruz-Flores, S., Wijman, C. A., Rapp, K. S., Grotta, J. C., & Lyden, P. D. (2010) · Stroke · doi:10.1161/strokeaha.110.592295 · Cited by 341
Dávalos, A., Toni, D., Iweins, F., Lesaffre, E., Bastianello, S., & Castillo, J. (1999) · Stroke · doi:10.1161/01.str.30.12.2631 · Cited by 332
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial
Kase, C. S., Furlan, A. J., Wechsler, L. R., Higashida, R. T., Rowley, H. A., Hart, R. G., Molinari, G. F., Frederick, L. S., Roberts, H. C., Gebel, J. M., et al. (2001) · Neurology · doi:10.1212/wnl.57.9.1603 · Cited by 332
Whiteley, W. N., Slot, K. B., Fernandes, P., Sandercock, P., & Wardlaw, J. (2012) · Stroke · doi:10.1161/strokeaha.112.665331 · Cited by 310
Self-citationTissue Plasminogen Activator for Acute Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342114 · Cited by 300
Donnan, G. A. (1996) · JAMA · doi:10.1001/jama.276.12.961 · Cited by 294
Zinkstok, S. M., & Roos, Y. B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60949-0 · Cited by 289
Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke
Wardlaw, J., Warlow, C., & Counsell, C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03022-5 · Cited by 287
Self-citationGrotta, J. C., Chiu, D., Lu, M., Patel, S., Levine, S. R., Tilley, B. C., Brott, T. G., Haley, E. C., Lyden, P. D., Kothari, R., et al. (1999) · Stroke · doi:10.1161/01.str.30.8.1528 · Cited by 286
Hill, M. D., Rowley, H. A., Adler, F., Eliasziw, M., Furlan, A., Higashida, R. T., Wechsler, L. R., Roberts, H. C., Dillon, W. P., Fischbein, N. J., et al. (2003) · Stroke · doi:10.1161/01.str.0000082483.37127.d0 · Cited by 283
Importance of Early Ischemic Computed Tomography Changes Using ASPECTS in NINDS rtPA Stroke Study
Demchuk, A. M., Hill, M. D., Barber, P. A., Silver, B., Patel, S. C., & Levine, S. R. (2005) · Stroke · doi:10.1161/01.str.0000181116.15426.58 · Cited by 269
Dzialowski, I., Hill, M. D., Coutts, S. B., Demchuk, A. M., Kent, D. M., Wunderlich, O., & von Kummer, R. (2006) · Stroke · doi:10.1161/01.str.0000206215.62441.56 · Cited by 252
Jauch, E. C., Lindsell, C., Broderick, J., Fagan, S. C., Tilley, B. C., & Levine, S. R. (2006) · Stroke · doi:10.1161/01.str.0000242290.01174.9e · Cited by 251
Lansberg, M. G., Lee, J., Christensen, S., Straka, M., De Silva, D. A., Mlynash, M., Campbell, B. C., Bammer, R., Olivot, J.-M., Desmond, P., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.609008 · Cited by 250
Ingall, T. J., O’Fallon, W. M., Asplund, K., Goldfrank, L. R., Hertzberg, V. S., Louis, T. A., & Christianson, T. J. H. (2004) · Stroke · doi:10.1161/01.str.0000140891.70547.56 · Cited by 250
Kent, D. M., Price, L. L., Ringleb, P., Hill, M. D., & Selker, H. P. (2005) · Stroke · doi:10.1161/01.str.0000150515.15576.29 · Cited by 239
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., del Zoppo, G. J., Yamaguchi, T., & Berge, E. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213 · Cited by 237
Self-citationDementia, stroke, and vascular risk factors; a review
Sahathevan, R., Brodtmann, A., & Donnan, G. A. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00731.x · Cited by 230
Dynamic of Hyperglycemia as a Predictor of Stroke Outcome in the ECASS-II Trial
Yong, M., & Kaste, M. (2008) · Stroke · doi:10.1161/strokeaha.108.514307 · Cited by 227
Hemorrhagic Transformation in Acute Ischemic Stroke: The MAST-E Study
Jaillard, A., Cornu, C., Durieux, A., Moulin, T., Boutitie, F., Lees, K. R., & Hommel, M. (1999) · Stroke · doi:10.1161/01.str.30.7.1326 · Cited by 225
Refining the Definition of the Malignant Profile: Insights From the DEFUSE-EPITHET Pooled Data Set
Mlynash, M., Lansberg, M. G., De Silva, D. A., Lee, J., Christensen, S., Straka, M., Campbell, B. C. V., Bammer, R., Olivot, J.-M., Desmond, P., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.601609 · Cited by 223
Hypertension and Its Treatment in the NINDS rt-PA Stroke Trial
Brott, T., Lu, M., Kothari, R., Fagan, S. C., Frankel, M., Grotta, J. C., Broderick, J., Kwiatkowski, T., Lewandowski, C., Haley, E. C., et al. (1998) · Stroke · doi:10.1161/01.str.29.8.1504 · Cited by 223
A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke
Haley, E. C., Lyden, P. D., Johnston, K. C., Hemmen, T. M., & the TNK in Stroke Investigators (2005) · Stroke · doi:10.1161/01.str.0000154872.73240.e9 · Cited by 222
Refining the Perfusion–Diffusion Mismatch Hypothesis
Butcher, K. S., Parsons, M., MacGregor, L., Barber, P. A., Chalk, J., Bladin, C., Levi, C., Kimber, T., Schultz, D., Fink, J., et al. (2005) · Stroke · doi:10.1161/01.str.0000166181.86928.8b · Cited by 222
ATLANTIS Trial: Results for Patients Treated Within 3 Hours of Stroke Onset
Albers, G. W., Clark, W. M., Madden, K. P., & Hamilton, S. A. (2002) · Stroke · doi:10.1161/hs0202.102599 · Cited by 212
Macleod, M. R., Davis, S. M., Mitchell, P. J., Gerraty, R. P., Fitt, G., Hankey, G. J., Stewart-Wynne, E. G., Rosen, D., McNeil, J. J., Bladin, C. F., et al. (2005) · Cerebrovascular Diseases · doi:10.1159/000086121 · Cited by 209
Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial
Grotta, J. C., Welch, K. M. A., Fagan, S. C., Lu, M., Frankel, M. R., Brott, T., Levine, S. R., & Lyden, P. D. (2001) · Stroke · doi:10.1161/01.str.32.3.661 · Cited by 196
Ma, H., Parsons, M. W., Christensen, S., Campbell, B. C. V., Churilov, L., Connelly, A., Yan, B., Bladin, C., Phan, T., Barber, A. P., et al. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00730.x · Cited by 195
Trials of streptokinase in severe acute ischaemic stroke
Shahar, E., McGovern, P., Hommel, M., Pierre Boissel, J., Donnan, G., Davis, S., Chambers, B., Gates, P., Hankey, G., McNeil, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90484-0 · Cited by 188
Pancioli, A. M., Broderick, J., Brott, T., Tomsick, T., Khoury, J., Bean, J., del Zoppo, G., Kleindorfer, D., Woo, D., Khatri, P., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.517656 · Cited by 187
Self-citationSaver, J. L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.7.1066 · Cited by 185
Thrombolysis in acute ischemic stroke: does it work?
Wardlaw, J. M., & Warlow, C. P. (1992) · Stroke · doi:10.1161/01.str.23.12.1826 · Cited by 183
Self-citationHaley, E. C., Brott, T. G., Sheppard, G. L., Barsan, W., Broderick, J., Marler, J. R., Kongable, G. L., Spilker, J., Massey, S., & Hansen, C. A. (1993) · Stroke · doi:10.1161/01.str.24.7.1000 · Cited by 181
Tanne, D., Bates, V. E., Verro, P., Kasner, S. E., Binder, J. R., Patel, S. C., Mansbach, H. H., Daley, S., Schultz, L. R., Karanjia, P. N., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.424 · Cited by 178
Tu, H. T. H., Campbell, B. C. V., Christensen, S., Desmond, P. M., De Silva, D. A., Parsons, M. W., Churilov, L., Lansberg, M. G., Mlynash, M., Olivot, J.-M., et al. (2015) · International Journal of Stroke · doi:10.1111/ijs.12007 · Cited by 176
The relation between treatment benefit and underlying risk in meta-analysis
Sharp, S. J., Thompson, S. G., & Altman, D. G. (1996) · BMJ · doi:10.1136/bmj.313.7059.735 · Cited by 172
Parsons, M. W., Christensen, S., McElduff, P., Levi, C. R., Butcher, K. S., De Silva, D. A., Ebinger, M., Barber, P. A., Bladin, C., Donnan, G. A., et al. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.3 · Cited by 161
Brown, D. L., Johnston, K. C., Wagner, D. P., & Haley, E. C. (2004) · Stroke · doi:10.1161/01.str.0000105396.93273.72 · Cited by 159
Termination of trial of streptokinase in severe acute ischaemic stroke
Hommel, M., Boissel, J. P., Cornu, C., Boutitie, F., Lees, K. R., Besson, G., Leys, D., Amarenco, P., Bogaert, M., & MAST Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)91179-0 · Cited by 159
Association of Characteristics of Blood Pressure Profiles and Stroke Outcomes in the ECASS-II Trial
Yong, M., & Kaste, M. (2007) · Stroke · doi:10.1161/strokeaha.107.492330 · Cited by 159
Thomalla, G., Fiebach, J. B., Østergaard, L., Pedraza, S., Thijs, V., Nighoghossian, N., Roy, P., Muir, K. W., Ebinger, M., Cheng, B., et al. (2013) · International Journal of Stroke · doi:10.1111/ijs.12011 · Cited by 159
Saver, J. L., & Altman, H. (2012) · Stroke · doi:10.1161/strokeaha.111.636928 · Cited by 158
Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke
Yamaguchi, T., Hayakawa, T., & Kiuchi, H. (1993) · Cerebrovascular Diseases · doi:10.1159/000108714 · Cited by 152
Silva, D. A. D., Fink, J., Christensen, S., Ebinger, M., Bladin, C., Levi, C. R., Parsons, M. W., Butcher, K., Barber, P. A., Donnan, G. A., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.543595 · Cited by 149
Broderick, J. P., Lü, M., Kothari, R., Levine, S. R., Lyden, P. D., Haley, E. C., Brott, T. G., Grotta, J. C., Tilley, B. C., Marler, J. R., et al. (2000) · Stroke · doi:10.1161/01.str.31.10.2335 · Cited by 148
MANELFE, C., Larrue, V., von Kummer, R., Bozzao, L., Ringleb, P. A., Bastianello, S., Iweins, F., & Lesaffre, E. M. E. H. (1999) · Stroke · doi:10.1161/01.str.30.4.769 · Cited by 146
Wardlaw, J. M., Sandercock, P. A., & Berge, E. (2003) · Stroke · doi:10.1161/01.str.0000072513.72262.7e · Cited by 142
Self-citationRoberts, H. C., Dillon, W. P., Furlan, A. J., Wechsler, L. R., Rowley, H. A., Fischbein, N. J., Higashida, R. T., Kase, C. S., Schulz, G. A., Lü, Y., et al. (2002) · Stroke · doi:10.1161/01.str.0000018011.66817.41 · Cited by 141
Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Marks, M. P., Holmgren, E. B., Fox, A. J., Patel, S. C., von Kummer, R., & Froehlich, J. (1999) · Stroke · doi:10.1161/01.str.30.2.389 · Cited by 141
Warlow, C., van Gijn, J., Dennis, M. S., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P. A., Rinkel, G. J. E., Langhorne, P., Sudlow, C. L. M., et al. (2008) · Wiley eBooks · doi:10.1002/9780470696361 · Cited by 139
Self-citationTilley, B. C., Lyden, P. D., Brott, T. G., Lü, M., Levine, S. R., & Welch, K. M. A. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550240020008 · Cited by 136
Pathophysiological Determinants of Worse Stroke Outcome in Atrial Fibrillation
Tu, H. T. H., Campbell, B. C. V., Christensen, S., Collins, M. L., Silva, D. A. D., Butcher, K., Parsons, M. W., Desmond, P. M., Barber, P. A., Levi, C. R., et al. (2010) · Cerebrovascular Diseases · doi:10.1159/000316886 · Cited by 134
Saver, J. L., GORNBEIN, J. A., Grotta, J. C., Liebeskind, D. S., Lutsep, H. L., Schwamm, L. H., Scott, P., & Starkman, S. (2009) · Stroke · doi:10.1161/strokeaha.108.543561 · Cited by 131
Hemorrhage After Thrombolytic Therapy for Stroke
Saver, J. L. (2007) · Stroke · doi:10.1161/strokeaha.107.487009 · Cited by 130
Tissue-plasminogen activator for acute ischaemic stroke
Bruno, A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61216-0 · Cited by 127
Campbell, B. C. V., Christensen, S., Butcher, K., Gordon, I., Parsons, M. W., Desmond, P. M., Barber, P. A., Levi, C. R., Bladin, C. F., Silva, D. A. D., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.562116 · Cited by 126
Steiner, T., Bluhmki, E., Kaste, M., Toni, D., Trouillas, P., von Kummer, R., & Hacke, W. (1998) · Cerebrovascular Diseases · doi:10.1159/000015851 · Cited by 124
The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
the IST-3 collaborative group, Sandercock, P. A., Lindley, R. I., Wardlaw, J. M., Dennis, M. S., Lewis, S. C., Venables, G. S., Kobayashi, A., Członkowska, A., Berge, E., et al. (2008) · Trials · doi:10.1186/1745-6215-9-37 · Cited by 122
Self-citationIschemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch
Chemmanam, T., Campbell, B. C. V., Christensen, S., Nagakane, Y., Desmond, P. M., Bladin, C., Parsons, M. W., Levi, C. R., Barber, P. A., Donnan, G. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f39ab6 · Cited by 121
Savitz, S. I., Lew, R., Bluhmki, E., Hacke, W., & Fisher, M. (2007) · Stroke · doi:10.1161/strokeaha.107.489351 · Cited by 119
Yong, M., Diener, H., Kaste, M., & Mau, J. (2005) · Stroke · doi:10.1161/01.str.0000189998.74892.24 · Cited by 118
Lenzer, J., Warlow, C., Saver, J. L., Kidwell, C. S., & Starkman, S. (2002) · BMJ · doi:10.1136/bmj.324.7339.723 · Cited by 115
The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2005.02.013 · Cited by 110
Hacke, W., Bluhmki, E., Steiner, T., Tatlisumak, T., Mahagne, M.-H., Sacchetti, M.-L., & Meier, D. (1998) · Stroke · doi:10.1161/01.str.29.10.2073 · Cited by 109
Myths Regarding the NINDS rt-PA Stroke Trial: Setting the Record Straight
Ec, H., Lewandowski, C., & Tilley, B. C. (1997) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(97)99996-0 · Cited by 109
Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST)
Sheffet, A., Roubin, G. S., Howard, G., Howard, V. J., Moore, W. S., Meschia, J. F., Hobson, R. W., & Brott, T. G. (2010) · International Journal of Stroke · doi:10.1111/j.1747-4949.2009.00405.x · Cited by 108
Day-90 Acute Ischemic Stroke Outcomes Can Be Derived from Early Functional Activity Level
Ovbiagele, B. I., & Saver, J. L. (2009) · Cerebrovascular Diseases · doi:10.1159/000255974 · Cited by 107
Lang, W., Stadler, C. H., Poljaković, Z., Fleet, D., & the Lyse Study Group (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00901.x · Cited by 104
Pantano, P., Caramia, F., Bozzao, L., Dieler, C., & von Kummer, R. (1999) · Stroke · doi:10.1161/01.str.30.3.502 · Cited by 103
Saver, J. L., & Yafeh, B. (2007) · Stroke · doi:10.1161/01.str.0000254580.39297.3c · Cited by 100
Hong, K., & Saver, J. L. (2010) · Stroke · doi:10.1161/strokeaha.109.571083 · Cited by 95
Sandercock, P. A., Berge, E., Dennis, M. S., Forbes, J., Hand, P. J., Kwan, J. S. K., Lewis, S. C., Lindley, R. I., Neilson, A. R., Thomas, B., et al. (2002) · Health Technology Assessment · doi:10.3310/hta6260 · Cited by 95
Self-citationHill, M. D., Kent, D. M., Hinchey, J. A., Rowley, H. A., Buchan, A. M., Wechsler, L. R., Higashida, R. T., Fischbein, N. J., Dillon, W. P., Gent, M., et al. (2006) · Stroke · doi:10.1161/01.str.0000237060.21472.47 · Cited by 94
Predicting Outcome in Ischemic Stroke
Johnston, K. C., Connors, A. F., Wagner, D. P., & Haley, E. C. (2003) · Stroke · doi:10.1161/01.str.0000047102.61863.e3 · Cited by 92
Qureshi, A. I., Harris‐Lane, P., Kirmani, J. F., Janjua, N. A., Divani, A. A., Mohammad, Y. M., Suárez, J. I., & Montgomery, M. O. (2006) · Neurosurgery · doi:10.1227/01.neu.0000232862.06246.3d · Cited by 91
Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review
Dundar, Y., Hill, R., Dickson, R., & Walley, T. (2003) · QJM · doi:10.1093/qjmed/hcg016 · Cited by 85
Rapid Assessment of Perfusion–Diffusion Mismatch
Butcher, K., Parsons, M. W., Allport, L., Lee, S. B., Barber, P. A., Tress, B. M., Donnan, G. A., & Davis, S. M. (2007) · Stroke · doi:10.1161/strokeaha.107.490524 · Cited by 84
Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke
Wardlaw, J. M., Koumellis, P., & Liu, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000514.pub3 · Cited by 83
Self-citationEmerging Therapies for Acute Ischemic Stroke: New Therapies on Trial
Fisher, M., & Brott, T. G. (2003) · Stroke · doi:10.1161/01.str.0000054627.69159.c2 · Cited by 83
Tanné, D., Macko, R. F., Lin, Y., Tilley, B. C., & Levine, S. R. (2006) · Stroke · doi:10.1161/01.str.0000226897.43749.27 · Cited by 81
Davis, S. M., & Donnan, G. A. (2009) · Stroke · doi:10.1161/strokeaha.108.544171 · Cited by 78
Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial
Ciccone, A., Valvassori, L., Ponzio, M., Ballabio, E., Gasparotti, R., Sessa, M., Scomazzoni, F., Tiraboschi, P., Sterzi, R., & the SYNTHESIS Investigators (2009) · Journal of NeuroInterventional Surgery · doi:10.1136/jnis.2009.001388 · Cited by 76
Demchuk, A. M., Khan, F., Hill, M. D., Barber, P. A., Silver, B., Patel, S. C., & Levine, S. R. (2008) · Cerebrovascular Diseases · doi:10.1159/000139658 · Cited by 69
Hemorrhage After an Acute Ischemic Stroke
Motto, C., Ciccone, A., Aritzu, E., et al. (1999) · Stroke · doi:10.1161/01.str.30.4.761 · Cited by 69
Intra-Arterial Fibrinolysis for Acute Ischemic Stroke: The Message of Melt
Saver, J. L. (2007) · Stroke · doi:10.1161/strokeaha.107.490417 · Cited by 69
The Effects of Alteplase 3 to 6 Hours After Stroke in the EPITHET–DEFUSE Combined Dataset
Ogata, T., Christensen, S., Nagakane, Y., Ma, H., Campbell, B. C. V., Churilov, L. P., Lansberg, M. G., Straka, M., Silva, D. A. D., Mlynash, M., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.668301 · Cited by 68
Are Patients With Acutely Recovered Cerebral Ischemia More Unstable?
Johnston, S. C., & Easton, J. D. (2003) · Stroke · doi:10.1161/01.str.0000090842.81076.68 · Cited by 66
Antithrombotic Drugs:Insights f rom Cardiology
Meyer, B. J. (1998) · Cerebrovascular Diseases · doi:10.1159/000047514 · Cited by 64
Thrombolytic Therapy for Acute Stroke — Not a Moment to Lose
Lyden, P. D. (2008) · New England Journal of Medicine · doi:10.1056/nejme0806335 · Cited by 64
Cronin, C. A. (2009) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2009.08.004 · Cited by 61
Visual Assessment of Perfusion-Diffusion Mismatch Is Inadequate to Select Patients for Thrombolysis
Campbell, B. C. V., Christensen, S., Foster, S. J., Desmond, P. M., Parsons, M. W., Butcher, K., Barber, P. A., Levi, C. R., Bladin, C. F., Donnan, G. A., et al. (2010) · Cerebrovascular Diseases · doi:10.1159/000311080 · Cited by 60
A Graphic Reanalysis of the NINDS Trial
Hoffman, J. R., & Schriger, D. L. (2009) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.03.019 · Cited by 60
Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke
von Kummer, R., Mori, E., Truelsen, T. C., Jensen, J.-K. S., Grønning, B. A., Fiebach, J. B., Lövblad, K., Pedraza, S., Romero, J. M., Chabriat, H., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013715 · Cited by 60
Kent, D. M., Ruthazer, R., & Selker, H. P. (2003) · Stroke · doi:10.1161/01.str.0000051506.43212.8b · Cited by 57
Third International Stroke Trial
Whiteley, W. N., Lindley, R. I., Wardlaw, J. M., & Sandercock, P. A. (2006) · International Journal of Stroke · doi:10.1111/j.1747-4949.2006.00043.x · Cited by 56
Self-citationFrontal lobe degeneration of non-Alzheimer type
Brun, A., & Passant, U. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00369.x · Cited by 56
Silva, D. A. D., Ebinger, M., Christensen, S., Parsons, M. W., Levi, C. R., Butcher, K., Barber, P. A., Bladin, C., Donnan, G. A., & Davis, S. M. (2009) · Cerebrovascular Diseases · doi:10.1159/000255969 · Cited by 55
Kwiatkowski, T., Libman, R., Tilley, B. C., Lewandowski, C., Grotta, J. C., Lyden, P. D., Levine, S. R., & Brott, T. G. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.06.021 · Cited by 53
Michel, P., Ntaios, G., Reichhart, M. D., Schindler, C., Bogousslavsky, J., Maeder, P., Meuli, R. A., & Wintermark, M. (2011) · Neuroradiology · doi:10.1007/s00234-011-0944-1 · Cited by 52
The Desmoteplase in Acute Ischemic Stroke (DIAS) Clinical Trial Program
von Kummer, R., Albers, G. W., & Mori, E. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00910.x · Cited by 51
A pilot study of streptokinase for acute cerebral infarction
Morris, A. D., Ritchie, C., Grosset, D. G., ADAMS, F. G., & Lees, K. R. (1995) · QJM · doi:10.1093/oxfordjournals.qjmed.a068997 · Cited by 44
Mann, J. (2005) · Stroke · doi:10.1161/01.str.0000164484.06950.77 · Cited by 44
Streptokinase in acute ischaemic stroke
Donnan, G. A., Hommel, M., Davis, S. M., & McNeil, J. J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92689-5 · Cited by 44
Graphic Reanalysis of the Two NINDS-tPA Trials Confirms Substantial Treatment Benefit
Saver, J. L., GORNBEIN, J. A., & Starkman, S. (2010) · Stroke · doi:10.1161/strokeaha.110.583807 · Cited by 42
Messe, S. R., Fonarow, G. C., Smith, E. E., Kaltenbach, L. A., Olson, D. M., Kasner, S. E., & Schwamm, L. H. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.964064 · Cited by 41
the IST-3 collaborative group, Sandercock, P. A., Lindley, R. I., Wardlaw, J. M., Dennis, M. S., Innes, K., Cohen, G., Whiteley, W. N., Perry, D., Soosay, V., et al. (2011) · Trials · doi:10.1186/1745-6215-12-252 · Cited by 41
Self-citationRetrograde Blood Flow in the Aortic Arch Determined by Transesophageal Doppler Ultrasound
Svedlund, S., Wetterholm, R., Volkmann, R., & Caidahl, K. (2008) · Cerebrovascular Diseases · doi:10.1159/000172630 · Cited by 39
Bruno, A., Saha, C., & Williams, L. S. (2008) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2008.09.002 · Cited by 38
Boysen, G., & The ECASS Study Group (1995) · European Journal of Neurology · doi:10.1111/j.1468-1331.1995.tb00074.x · Cited by 38
Kobayashi, A., Wardlaw, J. M., Lindley, R. I., Lewis, S. C., Sandercock, P. A., & Członkowska, A. (2009) · Stroke · doi:10.1161/strokeaha.108.526772 · Cited by 38
Self-citationvan Gils, M. J., Homburg, P. J., Rozie, S., de Weert, T. T., Dippel, D. W. J., & van der Lugt, A. (2010) · Cerebrovascular Diseases · doi:10.1159/000322152 · Cited by 37
Ischemic Preconditioning: A Novel Target for Neuroprotective Therapy
Blanco, M., Lizasoaín, I., Sobrino, T., Vivancos, J., & Castillo, J. (2006) · Cerebrovascular Diseases · doi:10.1159/000091702 · Cited by 37
Presumed Pathogenetic Mechanisms of Recurrent Stroke after Lacunar Infarction
Samuelsson, M., Lindell, D., & Norrving, B. G. (2007) · Cerebrovascular Diseases · doi:10.1159/000108012 · Cited by 36
A Topographic Study of the Evolution of the MR DWI/PWI Mismatch Pattern and Its Clinical Impact
Ogata, T., Nagakane, Y., Christensen, S., Ma, H., Campbell, B. C. V., Churilov, L. P., Olivot, J., Desmond, P. M., Albers, G. W., Davis, S. M., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.609016 · Cited by 35
Mandava, P., Kalkonde, Y. V., Rochat, R. H., & Kent, T. A. (2010) · Stroke · doi:10.1161/strokeaha.109.574103 · Cited by 35
Hyperglycemia Worsens Outcome After rt-PA Primarily in the Large-Vessel Occlusive Stroke Subtype
Mandava, P., Martini, S. R., Munoz, M., Dalmeida, W., Sarma, A. K., ANDERSON, J. A., Fabian, R. H., & Kent, T. A. (2014) · Translational Stroke Research · doi:10.1007/s12975-014-0338-x · Cited by 34
A User's Guide to the NINDS rt-PA Stroke Trial Database
Dachs, R. J., Burton, J. H., & Joslin, J. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050113 · Cited by 32
Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
Wein, T. H., Hickenbottom, S. L., Morgenstern, L. B., Demchuk, A. M., & Grotta, J. C. (2002) · Stroke · doi:10.1161/01.str.0000030108.47462.4f · Cited by 32
Sandercock, P. A., Lindley, R. I., Wardlaw, J. M., Whiteley, W. N., Murray, G. D., & on behalf of the IST-3 collaborative group (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00782.x · Cited by 31
Self-citationTruths about the NINDS study: setting the record straight
Mann, J. (2002) · Western Journal of Medicine · doi:10.1136/ewjm.176.3.192 · Cited by 30
Dissent: an alternative interpretation of MAST-I
Tognoni, G., & Roncaglioni, M. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92050-1 · Cited by 29
Ciccone, A., Motto, C., Aritzu, E., Piana, A., & Candelise, L. (2000) · Cerebrovascular Diseases · doi:10.1159/000016026 · Cited by 28
Application of Beta Regression to Analyze Ischemic Stroke Volume in NINDS rt-PA Clinical Trials
Swearingen, C. J., Tilley, B. C., Adams, R. J., Rumboldt, Z., Nicholas, J. S., Bandyopadhyay, D., & Woolson, R. F. (2011) · Neuroepidemiology · doi:10.1159/000330375 · Cited by 26
Derex, L., Tomsick, T. A., Brott, T. G., Lewandowski, C. A., Frankel, M., Clark, W. M., Starkman, S. J., Spilker, J. A., Udsten, G. J., Khoury, J. C., et al. (2001) · PubMed · Cited by 26
rt-PA for ischaemic stroke: what will the next question be?
Leys, D., & Cordonnier, C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60822-8 · Cited by 25
Saposnik, G., Demchuk, A. M., Tu, J. V., & Johnston, S. C. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.09.001 · Cited by 25
The Stroke Thrombolysis Trialists' Collaborative Group (2013) · International Journal of Stroke · doi:10.1111/ijs.12040 · Cited by 24
Trials of Thrombolysis in Acute Ischemic Stroke
Wardlaw, J. M., Sandercock, P. A., Warlow, C. P., et al. (2000) · Stroke · doi:10.1161/01.str.31.5.1133 · Cited by 23
Self-citationDesign of the Economic Evaluation for the Interventional Management of Stroke (III) Trial
Mauldin, P. D., Simpson, K. N., Palesch, Y. Y., Spilker, J. S., Hill, M. D., Khatri, P., & Broderick, J. P. (2008) · International Journal of Stroke · doi:10.1111/j.1747-4949.2008.00190.x · Cited by 23
Lou, M., & Selim, M. H. (2008) · Cerebrovascular Diseases · doi:10.1159/000175766 · Cited by 23
Risk Adjustment Effect on Stroke Clinical Trials
Johnston, K. C., Connors, A. F., Wagner, D. P., & Haley, E. C. (2004) · Stroke · doi:10.1161/01.str.0000109768.98392.4d · Cited by 22
Hemmen, T., Ernstrom, K. B., & Raman, R. (2011) · Stroke · doi:10.1161/strokeaha.110.608919 · Cited by 19
Bootstrap Statistics of ECASS II Data: Just Another post hoc Analysis of a Negative Stroke Trial?
Stingele, R., Bluhmki, E., & Hacke, W. (2001) · Cerebrovascular Diseases · doi:10.1159/000047608 · Cited by 18
Rhoney, D. H., Coplin, W. M., Lin, Y., Frankel, M., Lyden, P. D., & Levine, S. R. (2009) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.03.006 · Cited by 18
Why were the benefits of tPA exaggerated?: The role of interpretation bias
Trotter, G. (2002) · Western Journal of Medicine · doi:10.1136/ewjm.176.3.194 · Cited by 17
Surrogate Outcomes: A Cautionary Note
Wardlaw, J. M. (2009) · Stroke · doi:10.1161/strokeaha.108.540641 · Cited by 17
Self-citationThrombolytic therapy for acute ischaemic stroke: promising, perilous, or unproven?
Sandercock, P. A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92044-7 · Cited by 17
Patients at High Risk of Cerebrovascular Disease: The REACH Study
Mostaza, J. M., Martı́n-Jadraque, R., Vicente, I., Martín, M. A. S., & Lahoz, C. (2009) · Cerebrovascular Diseases · doi:10.1159/000200443 · Cited by 16
African American women have poor long-term survival following ischemic stroke
Qureshi, A. I., Suri, M. F. K., Zhou, J., & Divani, A. A. (2006) · Neurology · doi:10.1212/01.wnl.0000242756.00084.f9 · Cited by 16
Wang, S.-Y., Wang, X.-L., Zeng, H., Zuo, Y., Hu, N., Li, X., Huang, F., Yu, H., & Wang, H. (2003) · PubMed · Cited by 15
Polypill Strategy vs. Prevention Clinics for Stroke Prevention
Amarenco, P. (2006) · Cerebrovascular Diseases · doi:10.1159/000090360 · Cited by 13
Mandava, P., Murthy, S. B., Munoz, M., McGuire, D., Simon, R. P., Alexandrov, A. V., Albright, K. C., Boehme, A. K., Martin‐Schild, S., Martini, S. R., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001116 · Cited by 13
Georgiadis, A., Cordina, S. M., Vazquez, G., Tariq, N. A., Suri, M. F. K., Lakshminarayan, K., Adams, H. P., & Qureshi, A. I. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2011.06.017 · Cited by 13
The NINDS stroke study group response
Grotta, J. C. (2002) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2002.130044 · Cited by 11
Donnan, G. A. (2009) · International Journal of Stroke · doi:10.1111/j.1747-4949.2009.00245.x · Cited by 11
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Methods to Explain the Clinical Significance of Health Status Measures
Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.4.371 · Cited by 1,500
Metadata
- Authors
- Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-07-29
- Volume
- 2016
- Issue
- 1
- Pages
- CD000213-CD000213
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2131499646
- Cited by
- 1,370
- References
- 213
- FWCI
- 61.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.